ByBug

ByBug
Biotechnology startup using genetically engineered insects to convert organic waste into high-value recombinant proteins.
About
What does ByBug do?
ByBug is a Chilean biotechnology startup that utilizes genetically engineered black soldier flies to biomanufacture recombinant proteins and other sustainable bioproducts from agricultural byproducts and organic waste. Their technology, ByBug Synthetics, offers a more cost-effective and scalable alternative to traditional cell culture systems, with applications in animal health, nutrition, and industrial enzymes.
What is ByBug's revenue?
StartupHub estimates ByBug's annual revenue at $2.8M (range $1.5M to $7.3M, 68% confidence), based on comparable companies in the sector.
What is ByBug's valuation?
StartupHub estimates ByBug's effective valuation at $7.5M (range $4.9M to $11.8M, 22% confidence), based on comparable companies in the sector.
How much funding has ByBug raised?
ByBug has raised a total of $2M in funding. The most recent round on record is Equity Crowdfunding.
Where is ByBug headquartered?
ByBug is headquartered in Tulsa, United States.
When was ByBug founded?
ByBug was founded in 2021.
What industry does ByBug operate in?
ByBug operates in Biotechnology, Biomanufacturing, AgTech, Cleantech, Life Sciences, Insect Farming.
How many employees does ByBug have?
ByBug has approximately 20 people on record.
No comments yet. Be the first to share your take.
